HSCs and MSCs: What is the Difference?
What is the difference between hematopoietic stem cells and mesenchymal stem cells? Hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) can be found in tissues all over the body. Bone marrow is especially rich in HSCs. These “adult” stem cells are thought to have important roles in repairing and regenerating damaged tissue.
HSCs and MSCs found in cord blood, cord tissue, and placental tissue are called naïve, or early, stem cells. Naïve stem cells have some real advantages over adult stem cells. For instance, they’re less likely to cause rejection by the immune system.
HSCs have the ability to differentiate into any of the blood cells and cellular blood components in the body (such as white blood cells, red blood cells, and platelets).They’ve been used in medical treatments for over 25 years, and currently treat over 80 blood and bone-related conditions, including cancers of the blood, autoimmune disorders, and certain genetic disorders.
Unlike HSCs, MSCs readily differentiate into neurons as well as bone, cartilage, muscle, and fat tissue cells. MSCs aren’t currently FDA-approved for treatment, but researchers are very excited about their potential in the emerging fields of gene therapy and cellular repair. Extensive research is being pursued for MSC treatment of a host of conditions, including diabetes, heart disease, liver disease, stroke damage, spinal cord injury, and lung cancer.
Umbilical cord blood and tissue is rich in HSCs. MSCs are found in cord tissue as well, and also in placental tissue. Cord tissue contains MSCs that are related to the child, while placental tissue contains MSCs that are genetically unique to the mother and may possibly be used for future treatment for her or her child. And, Americord pioneered placental tissue banking and is one of the only cord blood banking companies that offers the service. Naïve MSCs are easily isolated and can be highly expanded in culture, widening the range of medical options for both children and adults.
Both hematopoietic and mesenchymal stem cells have the potential to be valuable resources to your family. HSCs provide proven treatment opportunities that are still being expanded and MSCs could possibly represent the future of regenerative medicine.
The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.